News

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis

BACKGROUND Metagenomic next-generation sequencing (NGS) of cerebrospinal fluid (CSF) has the potential to identify a broad range of pathogens in a single test.

GlaxoSmithKline taps UC’s CRISPR expertise to speed drug discovery

Jennifer Doudna and Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.

UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline

SAN FRANCISCO, May 29, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc.

Exploring a Patient-First Partnership

Published on Abbvie.com on May 23, 2019 - Link Making a Match Do your passions overlap? Do you have the same long-term goals? Are you willing to do long-distance from the Chicago area to San Francisco? Answering these questions may be reminiscent of online dating, but they have an important...

Tumor Regression Discovery Gets FDA Green Light

Once considered an undruggable target, the Shokat group discovered a novel, small molecule approach to induce tumor regression. The US FDA has cleared the IND application for clinical development.

Tmunity and UCSF Announce Collaboration

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers   – Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor – – Initial...

Scientists Create Speech From Brain Signals

A prosthetic voice decodes what the brain intends to say and generates (mostly) understandable speech, no muscle movement needed.

One Day There May Be a Drug to Turbocharge the Brain. Who Should Get It?

The Mysterious Hormone Called Klotho.

CRISPR-mediated Activation to Reduce Obesity

Catalyst awardees, Nadav Ahituv, PhD and Navneet Matharu, PhD, apply CRISPR-mediated activation to obesity. Here are the results:

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

- Comprised of an experienced leadership team, visionary investors, and renowned scientists in cell therapy, gene therapy, and gene editing - Brings together a portfolio of potential medicines and technologies - Led by Steve Harr, M.D. as CEO and Hans Bishop as Executive Chairman